Gilead Sciences Announces Fourth Quarter and Full Year 2012 Financial Results

From HIV i-Base

March/April 2013

On 4 February 2013, Gilead announced details of its antiviral product sales which increased 17 percent to $2.17 billion for the fourth quarter of 2012, up from $1.86 billion for the fourth quarter of 2011.

This reflects sales growth of 20 percent in the U.S. and 9 percent in Europe.

For 2012, antiviral product sales increased 15 percent to $8.14 billion from $7.05 billion in 2011, reflecting sales growth of 21 percent in the U.S. and 6 percent in Europe.

Source: Gilead press release. Gilead Sciences announces fourth quarter and full year 2012 financial results. (4 February 2013).

http://www.gilead.com/press

Links to other websites are current at date of posting but not maintained.

Blog Examines Drug Donation Programs, Big Pharma's Role in Public Health Agenda

GlaxoSmithKline to Make Clinical Trial Data Available to Other Researchers

This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.

More HIV Pharmaceutical Company News

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

More HIV Pharmaceutical Company News

"You don't have to fight this fight by yourself." Watch Susan's Story >

A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017

This Week in HIV Research: Injectable PrEP Shows Promise in New Study

How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today

PrEP Prescriptions Rise Sharply, but Unequally, in New York City

Riesgos del sexo oral receptivo

More >>

TheBody.com App

Get Our Newsletters

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.